The surprisingly positive treatment outcomes using Rigvir virotherapy for late stages cancer patients were recently published. The patients of melanoma stage IV M1c, small cell lung cancer stage IIIA ...
Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer: The Phase III PACIFIC-2 Study The following represents disclosure information ...
Cancer research has long looked at bacteria and viruses as separate tools for therapy. Now, researchers are showing that the two can actually work better together. A team of scientists has built a new ...
SAN DIEGO--(BUSINESS WIRE)--Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, ...
Add Yahoo as a preferred source to see more of our stories on Google. A scientist who managed to treat her breast cancer by injecting her tumor with viruses grown in a lab has ignited a debate ...
A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute has shown that a single injection of an oncolytic virus—a genetically modified virus that selectively infects and ...
NEEDHAM, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal ...
Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, will present new data at the American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results